Jeffrey E. Johnson, M.D., is a surgical oncologist at Mayo Clinic in Rochester, Minnesota, specializing in melanoma and breast cancer. He provides advanced cancer care, including sentinel lymph node biopsy, lymph node dissection, intralesional therapy, and tumor infiltrating lymphocyte (TIL) surgery for personalized treatment. Dr. Johnson offers expertise in neoadjuvant therapy, robotic nipple-sparing mastectomy, and high-risk breast cancer management. He is committed to patient-centered innovation and research to improve outcomes and expand treatment options.
Keywords Breast cancer surgeon, Jeffrey Johnson MD, Dr. Jeffrey Johnson, Atypical ductal hyperplasia, Atypical hyperplasia of the breast, Atypical lobular hyperplasia, BRCA gene mutation, Breast cancer, Breast cysts and lumps, Ductal carcinoma in situ, Fibroadenoma, HER2-positive breast cancer, Inflammatory breast cancer, Invasive ductal carcinoma, Invasive lobular carcinoma, Lobular carcinoma in situ, Luminal A breast cancer, Luminal B breast cancer, Male breast cancer, Medullary breast cancer, Melanoma, Merkel cell carcinoma, Mucinous breast cancer, Paget's disease of the breast, Paget's disease of the nipple, Papillary breast cancer, Phyllodes tumor, Recurrent breast cancer, Skin cancer, Squamous cell carcinoma of the breast, Squamous cell carcinoma of the skin, Stage 4 breast cancer, Triple-negative breast cancer, Triple-positive breast cancer, Tubular breast cancer, Breast abscess drainage, Breast biopsy, Breast cancer surgery, Breast duct excision, Breast surgery, Double mastectomy, Excisional biopsy, Lumpectomy, Lymph node biopsy, Lymphadenectomy, Mastectomy, Melanoma surgery, Minimally invasive surgery, Modified radical mastectomy, Nipple-sparing mastectomy, Oncoplastic breast-conserving surgery, Prophylactic mastectomy, Radioactive seed localization, Sentinel lymph node surgery, Sentinel node biopsy, Skin-sparing mastectomy, TVEC injection, Wire localization for breast surgery.